These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 19680727)
1. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Shu Yan Huo A; Lawson Morris D; King J; Glenn D Ann Surg Oncol; 2009 Nov; 16(11):3169-75. PubMed ID: 19680727 [TBL] [Abstract][Full Text] [Related]
2. [Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up]. Steinke K; King J; Glenn D; Morris DL Radiologe; 2004 Jul; 44(7):687-92. PubMed ID: 15232689 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
4. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up. Forauer AR; Dewey BJ; Seigne JD Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease. Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786 [TBL] [Abstract][Full Text] [Related]
7. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis]. Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025 [TBL] [Abstract][Full Text] [Related]
9. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation. Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408 [TBL] [Abstract][Full Text] [Related]
10. A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery. Sano Y; Kanazawa S; Mimura H; Gobara H; Hiraki T; Fujiwara H; Yamane M; Toyooka S; Oto T; Date H J Thorac Oncol; 2008 Mar; 3(3):283-8. PubMed ID: 18317072 [TBL] [Abstract][Full Text] [Related]
11. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses. Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience. Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma. Kim H; Park BK; Kim CK Korean J Radiol; 2008; 9(5):470-2. PubMed ID: 18838859 [TBL] [Abstract][Full Text] [Related]